Company News

The U.S. device sales tax, reimbursement and regulatory challenges and tightened healthcare spending all favour the installed company…so why not buy it?

Volcano’s revenue guidance is well down on last quarter, although the company says it’s actions to reduce costs will mean the bottom line looks unchanged.

Embattled spinal scaffold developer, InVivo Therapeutics looks like it’s got a hold of its finances as it proceeds down the rocky road through trials to ultimate approval.

Win Win as Symmetry Divests OEM Solutions to Tecomet for $450 million

Take out the $750 million settlement from Medtronic and Edwards would still be happy with a healthy sales increase over the equivalent quarter a year ago.

Medtronic, Inc. has completed the acquisition of Visualase, Inc., and its FDA-approved MRI-guided laser and image guided system for minimally invasive neurosurgery.

Sales ramped 4% compared with the equivalent period a year ago, but an increase in estimates of costs from pelvic mesh products liability cases saw S,G&A expenses ramp.

Atrial Fibrillation specialist AtriCure, Inc. has announced financial results for the second quarter of 2014.

New Senior Management and conclusion of a strategic review has seen ConMed renew its focus on delivering shareholder value, the company says.

Medical Device company Integra LifeSciences Holdings Corporation is making sure we all know that June 2014 marks the 25th anniversary of its founding.

Integrity Life Sciences has entered into an official global licensing agreement giving it the use of all of Axiom Worldwide’s technology and intellectual property.

Deliverer of light to MIS surgical sites, Invuity, Inc. has announced an agreement with one of the U.S.’ most prominent and nationally recognized purchasing organizations, Yankee Alliance, that will see its products being made available to thousands of its members.

Benvenue Medical, Inc. has closed out a $64 million funding round that it says will help it build its US commercial presence and generally support its growth objectives in the degenerative disc and vertebral compression fracture markets.

With a combined revenue of $27 Billion, the acquisition of Covidien by Medtronic makes for one helluva company that promises to have fingers in every conceivable medtech pie.

15 members of staff from Leeds-based device company Surgical Innovations are to cycle the route of the first stage in a bid to raise money for local charity The Sick Children’s Trust.

Echo Therapeutics, with its clever continuous glucose monitoring technology, is beset with woes coming mainly, so it seems from one dissident 20% shareholder. Now Echo’s board has written to shareholders questioning Platinum Group’s agenda in waging a costly and distracting proxy contest.

Recommends Stockholders Vote Revised White Proxy Card